Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BMS drug proves effective against arthritis
The new drug appears to offer pain relief and increased mobility to rheumatoid arthritis patients who have exhausted their other medical treatment options. Dr Mark Genovese, Stanford University
The new drug appears to offer pain relief and increased mobility to rheumatoid arthritis patients who have exhausted their other medical treatment options. Dr Mark Genovese, Stanford University
GSK is seeking US approval of Arranon for the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in pediatric and adult patients whose disease has not
The first of the two studies was designed to assess the effects of FM-VP4 in combination with Simvastatin (Zocor), a drug produced by Merck & Co, in rabbits
This decision follows a recent pre-biologics license application (BLA) meeting in which the company reviewed safety and efficacy data with the FDA from its two completed phase III
This pivotal clinical trial is intended to support a new drug application for the management of chronic lower back pain. The randomized trial will recruit approximately 600 outpatients
The generic versions of the drug will now compete in a market place where, according to NDCHealth, US sales of Glucophage XR 750mg were approximately $23 million in
Funding from the agency, which is part of the US Department of Health and Human Services, will be released in stages contingent upon the achievement of developmental milestones.
The study met its primary endpoint of non-inferiority to carbamazepine, an epilepsy drug produced by Novartis under the name Tegretol. The trial compared Keppra (levetiracetam) to sustained release
Health Canada has approved Erbitux (cetuximab) injection for use in combination with irinotecan in the treatment of patients with epidermal growth factor receptor expressing, metastatic colorectal cancer who
The biotech company’s sterile patch contains a concentration of sustained-release lidocaine. Under the protocol, investigators apply the patch directly over the incision upon closing and leave the patch